PurMinds Enterprises Inc PFSF
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.04–0.06
- 52-Week Range
- $0.01–0.13
- Bid/Ask
- $0.00 / $0.05
- Shares Outstanding
- 773.45M
- Market Cap
- $35.39M
- Volume/Avg
- 82,000 / 127,796
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
PurMinds Enterprises Inc is a precision neuro-medicine development company pursuing breakthrough solutions to neurological and psychiatric disorders. Its clinical pipeline includes novel, neuroprotective compounds that restore neuronal functions and can address multiple clinical indications with unmet patient needs. The group champions a "4P Medicine" platform, in strategic partnership with SpectroChip Global Inc., for early detection and intervention of conditions before irreversible damage occurs. PurMinds currently operates under a Health Canada-issued Controlled Drugs and Substances License.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 0
Valuation
|
Metric
|
PFSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PFSF
|
|---|---|
Quick Ratio | 2.81 |
Current Ratio | 2.81 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
PFSF
|
|---|---|
Return on Assets (Normalized) | −65.47% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|l#<?Qq | LOCK|J$zX% | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|ZTcs?n | LOCK|VYd& | $83B | |||
| argenx SE ADR
ARGX
| LOCK|^?>l$g | LOCK|!!> | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|yQv^T?W& | LOCK|Qfg!b | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|mdHtLP | LOCK|?&t | $42B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|SX&P%qc | LOCK|pq^G | $29B | |||
| Incyte Corp
INCY
| LOCK|?>Y$xG | LOCK|zn> | $25B | |||
| Moderna Inc
MRNA
| LOCK|d>^?>j | LOCK|<cJ | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|$LJvyh | LOCK|%k | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|g@yCT>W | LOCK|W! | $17B |
United States